Group One Trading’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8
| Closed | -$591 | – | 7673 |
|
|
2024
Q1 | $591 | Sell |
8
-112
| -93% | -$14.8K | ﹤0.01% | 6716 |
|
|
2023
Q4 | $21.4K | Buy |
120
+112
| +1,400% | +$55.1K | ﹤0.01% | 5701 |
|
|
2023
Q3 | $5.76K | Sell |
8
-1
| -11% | -$4.29K | ﹤0.01% | 6626 |
|
|
2023
Q2 | $39.3K | Sell |
9
-4
| -31% | -$13.9K | ﹤0.01% | 5466 |
|
|
2023
Q1 | $35.7K | Sell |
13
-83
| -86% | -$243K | ﹤0.01% | 5111 |
|
|
2022
Q4 | $251K | Buy |
96
+63
| +191% | +$220K | ﹤0.01% | 3670 |
|
|
2022
Q3 | $129K | Buy |
33
+26
| +371% | +$102K | ﹤0.01% | 4539 |
|
|
2022
Q2 | $19K | Buy |
7
+1
| +17% | +$2.6K | ﹤0.01% | 6341 |
|
|
2022
Q1 | $20K | Sell |
6
-2
| -25% | -$8.6K | ﹤0.01% | 6761 |
|
|
2021
Q4 | $49K | Sell |
8
-2
| -20% | -$15.4K | ﹤0.01% | 6360 |
|
|
2021
Q3 | $96K | Sell |
10
-12
| -55% | -$103K | ﹤0.01% | 5958 |
|
|
2021
Q2 | $226K | Buy |
22
+20
| +1,000% | +$329K | ﹤0.01% | 5113 |
|
|
2021
Q1 | $34K | Buy |
+2
| New | +$23.3K | ﹤0.01% | 6476 |
|
|
2016
Q2 | – | Hold |
0
| – | -$3K | – | 5012 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4324 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 3713 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 3670 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 3571 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 3030 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 3296 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 4173 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 3925 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 2826 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 2710 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 3668 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 3772 |
|
Other funds holding SEEL
Group One Trading's SEEL Position: Q4 2024 in Review
Group One Trading sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2024, closing a stake of 12 shares — an estimated $45 sold.
Group One Trading first reported a position in SEEL in Q2 2021 and held it in 13 quarters. The position peaked at $2.23M in Q3 2022. 2 funds tracked by Wall St. Rank hold SEEL as of Q4 2024.
- Group One Trading reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Group One Trading sold 12 Seelos Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $45.
- Group One Trading first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
- Group One Trading's Seelos Therapeutics, Inc. Common Stock position peaked at $2.23M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2024.
Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.